首页 | 本学科首页   官方微博 | 高级检索  
检索        

补肾活血液延缓雄性大鼠增龄性骨质疏松的研究
引用本文:张荣华,陆大祥,侯励,陈可冀,马晓昌.补肾活血液延缓雄性大鼠增龄性骨质疏松的研究[J].中国病理生理杂志,2001,17(12):1205-1207.
作者姓名:张荣华  陆大祥  侯励  陈可冀  马晓昌
作者单位:暨南大学药学院,暨南大学医学院第一附院,广东 广州 510632;中国中医研究院西苑医院,北京 100091
基金项目:广东省自然科学基金(No.990475);中国博士后科学基金(1999年第2期);广东省中医药管理局科学研究基金(No.99580、990475)资助项目
摘    要:目的:评价补肾活血液延缓雄性大鼠骨衰老的作用。方法:40只SD雄性大鼠随机分为4组,每组10只,分别为24月龄本底对照组、27月龄增龄对照组、补肾活血液低剂量组和补肾活血液高剂量组,增龄对照组不做任何处理,低剂量组、高剂量组均自24月龄给药至27月龄。进行相应处理后分别测定各组大鼠全身骨矿物密度(GBMD)、右侧股骨抗弯强度(FBS)和血清骨钙素(BGP)、尿羟脯氨酸(U-Hyp)与肌苷(U-Cr)。结果:补肾活血液高剂量组的GBMD及FBS均高于27月龄增龄对照组和补肾活血液低剂量组,但低于24月龄本底对照组;高剂量组的BGP明显高于增龄对照组(P<0.05),U-Hyp/Cr明显低于增龄对照组(P<0.05),都与本底对照组相接近;低剂量组的BGP低于本底对照组(P<0.05),U-Hyp/Cr明显高于本底对照组(P<0.05),都与增龄对照组相接近。结论:补肾活血液具有剂量依赖性地降低全身BMD的增龄性减少率和股骨抗弯强度的增龄性降低率,而延缓雄性大鼠增龄性骨质疏松的作用。

关 键 词:骨密度  骨质疏松  大鼠  中草药  
文章编号:1000-4718(2001)12-1205-03
收稿时间:2001-08-02
修稿时间:2001年8月2日

Effect of Chinese recipe of replenishing kidney and activating blood
ZHANG Rong-hua ,CHEN Ke-ji ,LU Da-xiang ,MA Xiao-chang ,HOU Li.Effect of Chinese recipe of replenishing kidney and activating blood[J].Chinese Journal of Pathophysiology,2001,17(12):1205-1207.
Authors:ZHANG Rong-hua  CHEN Ke-ji  LU Da-xiang  MA Xiao-chang  HOU Li
Institution:College of Pharmacy, First Affiliated Hospital of Medical College, Jinan University, Guangzhou 510632, China; Xiyuan Hospital, China Academy of Traditional Chinese Medicine, Beijing 100091, China
Abstract:AIM: To evaluate efficiency of Chinese recipe of replenishing kidney and activating blood circulation (CRRKABC) to stave senile osteoporosis(OP) of male rats. METHODS: Forty male SD rats at age o12 months were randomly divided into 4 groups: ①24 months background control; ②27 months aging control; ③CRRKABC (low dose) and ④CRRKABC (high dose). General bone mineral density (GBMD), femur bending strength (FBS), serum-BGP and urine-Hyp/Cr were measured. RESULTS: GBMD and FBS in CRRKABC (H) group were significantly higher than those in 27 months aging control group, but lower than 24 months background control group (P<0.05); GBMD, FBS in CRRKABC groups were slightly higher than those in nylestriol's group (P>0.05). Furthermore, the level of serum-BGP in CRRKABC(H) group was higher and level of U-Hyp/Cr was lower than 27 months aging control group (P<0.05) but very close to that of 24 months background control group. The level of serum-BGP in CRRKABC (L) group was lower and level of U-Hyp/Cr was higher than 24 months background control group (P<0.05) but very close to that of 27 months background control group. CONCLUSION: CRRKABC could control osteoporosis in male rats induced by aging, in a dosedependant manner.
Keywords:Bone density  Osteoporsis  Rats  Drugs  Chinese herbal  
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《中国病理生理杂志》浏览原始摘要信息
点击此处可从《中国病理生理杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号